Kimia Biosciences Ltd bags permission to manufacture and marketing of Azelnidipine API

Kimia Biosciences Ltd has been granted ‘permission to Manufacturing and Marketing of New Active pharmaceutical Ingredient Azelnidipine drug’ by Central Drugs Standard Control Organization, Ministry of Health & Family Welfare, FDA Bhawan, New Delhi – 110002(India) Vide permission No. MF/SND/20/000114 dated 28-April-2020 in FORM CT-22 under Drugs & Cosmetics Acts & Rules thereunder.